` OPL (Opyl Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

OPL
vs
S
S&P/ASX 300

Over the past 12 months, OPL has outperformed S&P/ASX 300, delivering a return of +21% compared to the S&P/ASX 300's +6% growth.

Stocks Performance
OPL vs S&P/ASX 300

Loading
OPL
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OPL vs S&P/ASX 300

Loading
OPL
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
OPL vs S&P/ASX 300

Loading
OPL
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Opyl Ltd vs Peers

S&P/ASX 300
OPL
PLTR
SAP
CRM
APP
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Opyl Ltd
Glance View

Market Cap
5.7m AUD
Industry
Technology

Opyl Ltd. is an information technology company. The company is headquartered in St Kilda, Victoria. The firm is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The firm has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The firm is also developing Clinical trial prediction and protocol design tool. The firm subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.

OPL Intrinsic Value
0.002 AUD
Overvaluation 89%
Intrinsic Value
Price
Back to Top